These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12591722)

  • 61. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines.
    Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
    J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Experimental research of RB94 gene transfection into retinoblastoma cells using ultrasound-targeted microbubble destruction.
    Zheng MM; Zhou XY; Wang LP; Wang ZG
    Ultrasound Med Biol; 2012 Jun; 38(6):1058-66. PubMed ID: 22502879
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Retinoblastoma 94 enhances radiation treatment of esophageal squamous cell carcinoma in vitro and in vivo.
    Zhang H; Li J; Wang YY; Meng AM; Liu Q; Wang L; Chen FH; Wang XC; Zhai ZB; Fu Y; Wang Q
    J Radiat Res; 2012; 53(1):117-24. PubMed ID: 22302052
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced.
    Zhang XQ; Dunner K; Benedict WF
    Cancer Gene Ther; 2010 Aug; 17(8):579-84. PubMed ID: 20489789
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Connecting chromosomes, crisis, and cancer.
    Maser RS; DePinho RA
    Science; 2002 Jul; 297(5581):565-9. PubMed ID: 12142527
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Telomerase activity and cellular apoptosis of bladder cancers].
    Qin Z; Mei H; Dai Y; Wang X; Chen X; Chen Q
    Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):697-9. PubMed ID: 11832143
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1.
    Jin Y; Murata H; Sakaguchi M; Kataoka K; Watanabe M; Nasu Y; Kumon H; Huh NH
    Oncol Rep; 2012 Mar; 27(3):695-9. PubMed ID: 22076283
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adenoviral-mediated interferon alpha overcomes resistance to the interferon protein in various cancer types and has marked bystander effects.
    Zhang X; Yang Z; Dong L; Papageorgiou A; McConkey DJ; Benedict WF
    Cancer Gene Ther; 2007 Mar; 14(3):241-50. PubMed ID: 17096027
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Telomere length and telomerase activity in the process of human fibroblast immortalization.
    Kumakura S; Yamamoto A; Yagisawa J; Uchida M; Tsutsui T
    Odontology; 2002 Sep; 90(1):13-21. PubMed ID: 12955560
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.
    Benedict WF; Tao Z; Kim CS; Zhang X; Zhou JH; Adam L; McConkey DJ; Papageorgiou A; Munsell M; Philopena J; Engler H; Demers W; Maneval DC; Dinney CP; Connor RJ
    Mol Ther; 2004 Sep; 10(3):525-32. PubMed ID: 15336652
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular targeting and gene delivery in bladder cancer therapy.
    Voutsinas GE; Stravopodis DJ
    J BUON; 2009 Sep; 14 Suppl 1():S69-78. PubMed ID: 19785072
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hydroxyl radical-induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and caspase activation.
    Ren JG; Xia HL; Just T; Dai YR
    FEBS Lett; 2001 Jan; 488(3):123-32. PubMed ID: 11163758
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo.
    Pirollo KF; Rait A; Zhou Q; Zhang XQ; Zhou J; Kim CS; Benedict WF; Chang EH
    Clin Cancer Res; 2008 Apr; 14(7):2190-8. PubMed ID: 18381961
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rb knockdown accelerates bladder cancer progression through E2F3 activation.
    Wang JP; Jiao Y; Wang CY; Xu ZB; Zhang B
    Int J Oncol; 2017 Jan; 50(1):149-160. PubMed ID: 27922689
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthetic nucleosides and nucleotides. 43. Inhibition of vertebrate telomerases by carbocyclic oxetanocin g (C.OXT-G) triphosphate analogues and influence of C.OXT-G treatment on telomere length in human HL60 cells.
    Yamaguchi T; Saneyoshi M; Takahashi H; Hirokawa S; Amano R; Liu X; Inomata M; Maruyama T
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):539-51. PubMed ID: 16838844
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Telomerase targeting in cancer treatment: new developments.
    Helder MN; Jong S; Vries EG; Zee AG
    Drug Resist Updat; 1999 Apr; 2(2):104-115. PubMed ID: 11504478
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rebuilding the road to cancer.
    Weitzman JB; Yaniv M
    Nature; 1999 Jul; 400(6743):401-2. PubMed ID: 10440363
    [No Abstract]   [Full Text] [Related]  

  • 78. Conditioned medium from Ad-IFN-alpha-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect.
    Zhang X; Dong L; Chapman E; Benedict WF
    Cancer Gene Ther; 2008 Dec; 15(12):817-22. PubMed ID: 18617914
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rb1 haploinsufficiency promotes telomere attrition and radiation-induced genomic instability.
    Gonzalez-Vasconcellos I; Anastasov N; Sanli-Bonazzi B; Klymenko O; Atkinson MJ; Rosemann M
    Cancer Res; 2013 Jul; 73(14):4247-55. PubMed ID: 23687339
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rb deficiency accelerates progression of carcinoma of the urinary bladder in vivo and in vitro through inhibiting autophagy and apoptosis.
    Wang CY; Xu ZB; Wang JP; Jiao Y; Zhang B
    Int J Oncol; 2017 Apr; 50(4):1221-1232. PubMed ID: 28259945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.